With our single-point-of-contact approach to procurement, customers always have a reliable and accountable partner close-at-hand, and are not required to coordinate with 3-5 points of contact throughout the purchasing journey.
Finally, we own the supply chain – providing a high degree of control over the complex dependencies necessary to commercialize and deliver best-in-class generic and biosimilar therapeutic products.